Security key
81728A207
Faeth Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FTH)
CUSIP: 81728A207
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 2,156,465
- Total 13F value
- $67,971,428
- Share change
- +2,094,161
- SEC-reported price per share
- $31.52
- Number of holders
- 30
- Value change
- +$66,014,101
- Number of buys
- 23
- Number of sells
- 3
- Shares outstanding
- 25,898,756
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
30
Top holders
10
FTH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Faeth Therapeutics, Inc. SEC filings
Faeth Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 81728A207
Recent filing periods:
Ownership snapshot
Top reported holders of FTH - Faeth Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
STEMPOINT CAPITAL LP
Disclosed value leader
STEMPOINT CAPITAL LP
Comparable rows
13/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
2 rows are not safely comparable across share classes.
13D/G row: STEMPOINT CAPITAL LP
Showing 1-6 of 15 holder rows.
Quick read
STEMPOINT CAPITAL LP leads the comparable SEC ownership view at 9.9%.
13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens STEMPOINT CAPITAL LP's linked filing trail.
Comparable ownership
Top 5
STEMPOINT CAPITAL LP
9.9%
Trails Edge Capital Partners, LP
9.9%
Caligan Partners LP
9.4%
Ikarian Capital, LLC
0.08%
Catalio Capital Management, LP
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| STEMPOINT CAPITAL LP |
13D/G
|
9.9%
|
$4,006,121
132,873 shares
|
$0 | 31 Mar 2026 |
| Trails Edge Capital Partners, LP |
13D/G
|
9.9%
|
$1,217,257
126,010 shares
|
$0 | 18 Feb 2026 |
| Caligan Partners LP |
13D/G
|
9.4%
|
$3,798,960
126,002 shares
|
$0 | 31 Mar 2026 |
| Ikarian Capital, LLC |
13F
Company
|
0.08%
|
$227,815
21,351 shares
|
— | 31 Dec 2025 |
| Catalio Capital Management, LP |
13F
Company
|
0.06%
|
$157,041
14,718 shares
|
— | 31 Dec 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.04%
|
$122,876
11,516 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
2,156,465
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
10
Q1 2026 holders
30
Holder diff
20
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend